# Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018

> **NCT06056011** · NA · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 373 (actual)

## Conditions studied

- Febrile Illness

## Interventions

- **DEVICE:** Connex CVSM with Timmy3 module

## Key facts

- **NCT ID:** NCT06056011
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-19
- **Primary completion:** 2025-03-18
- **Final completion:** 2025-03-18
- **Target enrollment:** 373 (ACTUAL)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06056011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06056011, "Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06056011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*